Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-26

Clinical Trial Update: Tolerability and Acceptability of Fibersol-2 in Children [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting tolerability and acceptability of Fibersol-2 in children in Phase 1 and Phase 2 for diarrhea; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibersol-2 (resistant maltodextrin)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Diarrhea | Phase 1, Phase 2 | Status: COMPLETED